MARKET RADAR
SENSEX     NIFTY      
Plethico Pharmaceuticals Key Financial Ratios, Plethico Pharmaceuticals Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Key Financial Ratios - Plethico Pharmaceuticals
Plethico Pharmaceuticals
BSE: 532739|NSE: PLETHICO|ISIN: INE491H01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 17:00
368.80
-2.4 (-0.65%)
VOLUME 34,808
LIVE
NSE
Feb 10, 17:00
367.10
-2.75 (-0.74%)
VOLUME 31,114

Key Financial Ratios of Plethico Pharmaceuticals

Dec '10 Dec '09 Dec '08 Dec '07 Sep '06
Investment Valuation Ratios
Face Value 10.00 10.00 10.00 10.00 10.00
Dividend Per Share 2.50 2.50 2.50 2.50 2.50
Operating Profit Per Share (Rs) 38.44 40.72 28.66 48.58 27.15
Net Operating Profit Per Share (Rs) 131.37 139.24 139.35 161.96 93.81
Free Reserves Per Share (Rs) 194.82 188.06 167.39 161.96 118.36
Bonus in Equity Capital 85.44 85.44 85.44 85.44 85.44
Profitability Ratios
Operating Profit Margin(%) 29.25 29.24 20.56 29.99 28.94
Profit Before Interest And Tax Margin(%) 27.56 27.90 18.74 28.64 27.28
Gross Profit Margin(%) 27.59 27.93 19.01 28.77 27.33
Cash Profit Margin(%) 17.08 22.50 17.29 27.89 28.48
Adjusted Cash Margin(%) 17.08 22.50 17.29 27.89 26.51
Net Profit Margin(%) 12.92 22.53 26.80 25.60 26.87
Adjusted Net Profit Margin(%) 12.92 22.53 26.80 25.60 24.71
Return On Capital Employed(%) 9.52 10.35 7.55 16.33 16.21
Return On Net Worth(%) 8.29 15.86 21.36 24.21 19.38
Adjusted Return on Net Worth(%) 9.62 14.63 12.25 24.93 18.09
Return on Assets Excluding Revaluations 204.82 198.06 177.39 171.96 14.94
Return on Assets Including Revaluations 204.82 198.06 177.39 171.96 14.94
Return on Long Term Funds(%) 9.81 10.62 8.03 17.11 17.43
Liquidity And Solvency Ratios
Current Ratio 2.97 3.82 2.25 3.88 2.78
Quick Ratio 6.01 8.29 8.37 11.12 8.05
Debt Equity Ratio 0.83 0.87 1.07 0.65 0.21
Long Term Debt Equity Ratio 0.78 0.82 0.94 0.57 0.13
Debt Coverage Ratios
Interest Cover 4.14 4.51 5.58 16.90 15.74
Total Debt to Owners Fund 0.83 0.87 1.07 0.65 0.21
Financial Charges Coverage Ratio 3.73 4.35 5.69 16.26 15.58
Financial Charges Coverage Ratio Post Tax 2.91 4.59 8.54 15.57 16.37
Management Efficiency Ratios
Inventory Turnover Ratio 43.37 37.02 45.56 50.63 22.59
Debtors Turnover Ratio 1.30 1.40 1.56 2.26 1.91
Investments Turnover Ratio 43.37 37.02 45.56 50.63 28.23
Fixed Assets Turnover Ratio 2.41 3.22 3.22 3.95 2.97
Total Assets Turnover Ratio 0.35 0.37 0.38 0.57 0.59
Asset Turnover Ratio 2.41 3.22 3.22 3.95 2.76
Average Raw Material Holding 10.24 11.06 7.24 7.99 8.29
Average Finished Goods Held 3.35 4.07 4.09 5.65 10.41
Number of Days In Working Capital 292.75 295.70 308.24 363.83 311.75
Profit & Loss Account Ratios
Material Cost Composition 51.90 50.27 60.17 58.53 61.48
Imported Composition of Raw Materials Consumed 6.95 21.78 21.49 18.82 0.23
Selling Distribution Cost Composition 6.19 11.13 8.01 3.88 2.75
Expenses as Composition of Total Sales 58.62 65.03 56.49 62.64 57.77
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 17.09 9.27 7.71 7.02 11.28
Dividend Payout Ratio Cash Profit 14.71 8.62 7.20 6.62 10.58
Earning Retention Ratio 85.26 89.95 86.55 93.18 87.73
Cash Earning Retention Ratio 87.07 90.71 88.04 93.56 88.56
AdjustedCash Flow Times 7.59 5.51 7.82 2.47 1.11
Dec '10 Dec '09 Dec '08 Dec '07 Sep '06
Earnings Per Share 17.00 31.42 37.90 41.65 25.25
Book Value 205.26 199.06 178.95 174.09 130.27
Source : Dion Global Solutions Limited
Explore Plethico Pharma connections

Results of Plethico Pharma

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for plethicopharmaceuticals
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.